CoChat

miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target

Open access
Serocki, Marcin, Bartoszewska, Sylwia, Janaszak-Jasiecka, Anna, Ochocka, Renata J., Collawn, James F., Bartoszewski, Rafał · 2018 · Angiogenesis

The DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.

Abstract

The decline of oxygen tension in the tissues below the physiological demand leads to the hypoxic adaptive response. This physiological consequence enables cells to recover from this cellular insult. Understanding the cellular pathways that mediate recovery from hypoxia is therefore critical for developing novel therapeutic approaches for cardiovascular diseases and cancer. The master regulators of oxygen homeostasis that control angiogenesis during hypoxia are hypoxia-inducible factors (HIFs). HIF-1 and HIF-2 function as transcriptional regulators and have both unique and overlapping target genes, whereas the role of HIF-3 is less clear. HIF-1 governs the acute adaptation to hypoxia, whereas HIF-2 and HIF-3 expressions begin during chronic hypoxia in human endothelium. When HIF-1 levels decline, HIF-2 and HIF-3 increase. This switch from HIF-1 to HIF-2 and HIF-3 signaling is required in order to adapt the endothelium to prolonged hypoxia. During prolonged hypoxia, the HIF-1 levels and activity are reduced, despite the lack of oxygen-dependent protein degradation. Although numerous protein factors have been proposed to modulate the HIF pathways, their application for HIF-targeted therapy is rather limited. Recently, the miRNAs that endogenously regulate gene expression via the RNA interference (RNAi) pathway have been shown to play critical roles in the hypoxia response pathways. Furthermore, these classes of RNAs provide therapeutic possibilities to selectively target HIFs and thus modulate the HIF switch. Here, we review the significance of the microRNAs on the relationship between the HIFs under both physiological and pathophysiological conditions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10456-018-9600-2

Cites

174 of 174 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Schematic representation of the HIF subunit domain structures. ODD oxygen-dependent degradation domain, bHLH basic helix–loop–helix, PAS PER–ARNT–SIM, TAD transactivation domain, aa number of amino acid residues
Fig. 1 Schematic representation of the HIF subunit domain structures. ODD oxygen-dependent degradation domain, bHLH basic helix–loop–helix, PAS PER–ARNT–SIM, TAD transactivation domain, aa number of amino acid residuesCC BY · PubMed Central
Fig. 2 Hypoxia (0.8% O2) induces dynamic changes in the protein expression profile of the Hif-1α, Hif-2α and HIF-3α in primary HUVECs (pooled from 10 donors, passage 3). The protein levels of were detected with SDS-PAGE and Western blot and normalized to β Actin levels. Two individual samples (20 µg of total protein per lane) were tested for each time point, and the experiments were repeated twice. The primary antibodies used were: Hif-1α (Abcam ab16066, diluted at 1:2000); Hif-2α (Abcam ab199, diluted at 1:1000), Hif-3α [12] (Sigma AV39936, diluted at 1:1000), beta Actin (Abcam ab1801, diluted at 1:1000)
Fig. 2 Hypoxia (0.8% O2) induces dynamic changes in the protein expression profile of the Hif-1α, Hif-2α and HIF-3α in primary HUVECs (pooled from 10 donors, passage 3). The protein levels of were detected with SDS-PAGE and Western blot and normalized to β Actin levels. Two individual samples (20 µg of total protein per lane) were tested for each time point, and the experiments were repeated twice. The primary antibodies used were: Hif-1α (Abcam ab16066, diluted at 1:2000); Hif-2α (Abcam ab199, diluted at 1:1000), Hif-3α [12] (Sigma AV39936, diluted at 1:1000), beta Actin (Abcam ab1801, diluted at 1:1000)CC BY · PubMed Central
Fig. 3 Schematic representation of the miRNA role in the HIF switch regulation
Fig. 3 Schematic representation of the miRNA role in the HIF switch regulationCC BY · PubMed Central
Fig. 4 Potential miRNA therapeutic strategies. a agomiRs—exogenous miRNA overexpression impairs translation and leads to decreased stability of the majority of the target mRNAs. b antagomiRs—reduction of endogenous miRNA levels leads to increased stability and translation of the majority of the target mRNAs c. Target protector prevents miRNA binding to a defined specific target mRNA, leading to increased stability and translation of this mRNA (without any impact on other potential mRNA targets)
Fig. 4 Potential miRNA therapeutic strategies. a agomiRs—exogenous miRNA overexpression impairs translation and leads to decreased stability of the majority of the target mRNAs. b antagomiRs—reduction of endogenous miRNA levels leads to increased stability and translation of the majority of the target mRNAs c. Target protector prevents miRNA binding to a defined specific target mRNA, leading to increased stability and translation of this mRNA (without any impact on other potential mRNA targets)CC BY · PubMed Central
Fig. 5 Schematic representation of the morpholino structures complementarily to the mRNA. Morpholinos have a modification of the natural RNA in which the 5-membered sugar ring is replaced by the 6-membered morpholine ring and the negatively charged phosphate intersubunit linkages are replaced by nonionic phosphorodiamidate intersubunit linkages
Fig. 5 Schematic representation of the morpholino structures complementarily to the mRNA. Morpholinos have a modification of the natural RNA in which the 5-membered sugar ring is replaced by the 6-membered morpholine ring and the negatively charged phosphate intersubunit linkages are replaced by nonionic phosphorodiamidate intersubunit linkagesCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 174 references

Research works printed but not linked: 1

  1. Koh MY, Powis G (2006) SART1/HAF, a protein widely over expressed in human cancer, decreases HIF-1α levels and inhibits tumor growth. Can Res 66(8 Supplement):409

Cited by

See all 288

Metadata

Authors
Serocki, M., Bartoszewska, S., Janaszak-Jasiecka, A., Ochocka, R. J., Collawn, J. F., & Bartoszewski, R.
Affiliations
  • Gdańsk Medical University (PL)
  • University of Alabama at Birmingham (US)
Corresponding author
Bartoszewski, Rafał
Venue
Angiogenesis
Published
2018-01-27
Volume
21
Issue
2
Pages
183-202
ISSN
  • 0969-6970 (ISSN-L)
  • 1573-7209
OpenAlex
W2787814498
Cited by
288
References
174
Citations by year
2026: 21 · 2025: 27 · 2024: 34 · 2023: 51 · 2022: 45 · 2021: 48 · 2020: 35 · 2019: 23 · 2018: 4
FWCI
2.83
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0 (tdm)
Locations
  • Angiogenesis (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (NIH P30 DK072482, DK072482)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK072482)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
Keywords
microRNA, hypoxia-inducible factor, HIF-1, HIF-2, hypoxia adaptation, oxygen homeostasis, endothelial cells, chronic hypoxia, HIF-targeted therapy, cardiovascular disease, cancer
MeSH terms
Animals, Hypoxia, Gene Expression Regulation, Humans, Transcription, Genetic, Signal Transduction, MicroRNAs, Basic Helix-Loop-Helix Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target. https://app.cochat.ai/papers/10.1007/s10456-018-9600-2
The paper
Serocki, M., Bartoszewska, S., Janaszak-Jasiecka, A., Ochocka, R. J., Collawn, J. F., & Bartoszewski, R. (2018). miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target. Angiogenesis. https://doi.org/10.1007/s10456-018-9600-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.